Sports

The LA Chargers ‘Charged’ to Take the AFC West

Published

4 years ago

July 15, 2021

Jonathan Grilli

Can the Los Angeles Chargers streal the AFC West away from the Kansas City Chiefs in the 2021-2022 season?

If you remember last season, the LA Chargers handed the Kansas City Chiefs a 38-21 loss on January 3^rd.

This was one of just two losses for the recent Champs and back-to-back Super Bowl participants. The other came at the hands of Jon Gruden’s Las Vegas Raiders, the black sheep of the AFC West.

The other game the Chargers played against the Chiefs went right down to the wire as well. In Week 2, the Chargers and their stud of a rookie QB took KC into overtime and lost 23-20.

One thing is for sure, even if the Chargers don’t win the division this year, this is a team that is coming up in a big way.

Odds on the AFC West

The market from top bookmakers at Illinois opened with the betting lines showing the Kansas City Chiefs at -455; the LA Chargers at +525; the LV Raiders at +1400; and the Denver Broncos at +1500.

These lines showed that sportsbooks around the globe thought the Chargers were poised to be the second-best team in the AFC West and significantly more likely to win the division than the Raiders or Broncos.

But even though no announcements have been made, bookmakers believe that Aaron Rodgers will find his way to Mile High in 2021. So much so that the Denver Broncos have jumped the Chargers on the boards at most betting outlets and currently hold that No. 2 spot. The Broncos now have odds as short as +400 to win the west.

But how much will it matter? Even if Aaron Rodgers does move to Denver, the offensive line isn’t great—rated by Pro Fantasy Football at No. 25 in the league—and Rodgers still doesn’t have the most outstanding targets. Sure, the potential is there, and some experts are touting the Denver receiving corps as high as No. 6 in the NFL … but let’s be honest, Cortland Sutton missed most of the season, and we are not sure what the Broncos will be getting back at this point. Then there are two highly touted young receivers in K.J. Hamler and Jerry Jeudy but what we have seen from them is just handfuls of dropped passes—or figurative handfuls, because they can’t keep the ball in their hands.

As far as the O-lines are concerned, the Chargers look much better than Denver. Bryan Bulga is back and healthy and is continually graded at 75.0 or better. On top of Bulga being back to top form, the Chargers grabbed another former Green Bay big-man in Corey Linsley. This snapper was, in many eyes, the top free-agent center on the market.

The Chargers also have some solid back-ups on the line, namely Brenden James. The young guard needs to work on his run-blocking but is a solid pass protector, which is just what Justin Herbert needs when Oday Aboushi takes a breather or goes down with a stinger.

Although the Chargers are far from boasting the best offensive line in the league, they may have the most improved line in the entire NFL.

If the Chargers win the games they need and split wins with the KC Chiefs again; they could take the AFC West. After all, the LA Chargers are tied for the 3rd most manageable schedule in the league when the SOS is based on current season win projections—using the win/loss over/under totals for each team on the schedule instead of last season’s record.

Will they actually win the AFC West? Probably not; the Chiefs are loaded. But hey, you never know. That said, I believe the Chargers are poised for a wild card berth in 2021-2022, and this team will continue to surprise with upset wins over teams that are better on paper.

What are the odds that the Chargers will get nine wins and make a solid run on the division but fall short to a 12-wins Chiefs squad? We will find out.

Sports

Professional basketball player Kévin Noulowe is close to finalizing a million-dollar sponsorship deal with the Bioscience Stem Cell Institute of Dubai

Published

2 months ago

February 27, 2025

Jonathan Grilli

Kévin Noulowe, a 6’10” professional basketball player, is close to finalizing a million-dollar sponsorship deal with the Bioscience Stem Cell Institute of Dubai, a partnership that could redefine the way athletes and individuals suffering from chronic pain approach healing and recovery.

The star basketball player is known for his athleticism, strength, and dominance on the court but is also known for having to battle injuries throughout his career. Noulowe is turning his attention to regenerative medicine, advocating for stem cell therapy as a breakthrough alternative to invasive surgeries and prolonged rehabilitation. With his towering presence in the sports world, Noulowe aims to bring awareness to the transformative potential of stem cell treatments, particularly for athletes, aging individuals, and those struggling with debilitating conditions.

Stem cell therapy, a rapidly advancing field of regenerative medicine, has gained attention for its ability to repair damaged tissues, accelerate healing, and reduce inflammation without the risks and downtime associated with traditional surgeries. Noulowe, who has seen firsthand how injuries can impact a player’s career, believes this treatment could offer a game-changing solution for athletes looking to recover faster and stay in peak condition.

Beyond the world of sports, Noulowe envisions a broader impact. His partnership with the Dubai-based stem cell institute is driven by a mission to help people across all walks of life—newborns, women, the elderly, and those suffering from chronic pain—access cutting-edge medical advancements that have the potential to restore mobility and improve quality of life.

The deal, while not yet officially signed, is in its final stages, with both parties working toward an agreement that will see Noulowe leverage his platform to promote stem cell awareness on a global scale. His advocacy comes at a time when regenerative medicine is gaining traction as a viable alternative to conventional treatments, with research showing promising results in pain management, injury recovery, and long-term health improvement.

For professional athletes, the implications are significant. Instead of relying on surgeries that can sideline careers and come with long-term consequences, players could turn to regenerative treatments that offer quicker recovery and potentially longer playing careers. Noulowe sees this as an opportunity to introduce a new era in sports medicine, where cutting-edge treatments replace outdated methods of rehabilitation.

While the details of the partnership are still being finalized, Noulowe remains committed to raising awareness and making regenerative medicine more accessible. His vision extends beyond basketball, as he seeks to create a lasting impact on how people worldwide approach healing and recovery.

As discussions near completion, anticipation is growing around what this collaboration could mean for the future of stem cell therapy in both the medical and athletic communities. Noulowe’s influence, combined with scientific advancements in regenerative medicine, has the potential to change the way injuries and chronic pain are treated—ushering in a new frontier of healing.